At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Growth Hormone Replacement in Adults With Growth Hormone Deficiency (GHD) - The Effect on Liver Fat.
In Brief
An observational study for Growth Hormone, Recombinant and Fatty Liver. Completed, enrolled 30 participants across 1 site.
Detailed Summary
We will examine a cohort of growth hormone deficient adults starting growth hormone (GH) replacement. The purpose of this study is to determine whether GH replacement reduces the fat content of the liver. To compare the results we will include growth hormone deficient patients who do not start GH replacement as controls.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGrowth Hormone, Recombinant, Fatty Liver
CountriesUnited Kingdom
CollaboratorsNovo Nordisk A/S
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2008
First PostedOct 2008
Primary CompletionMar 2009
Study CompletionOct 2009
TodayJul 2026
First PostedOct 17, 2008
Enrollment StartMar 1, 2008
Primary CompletionMar 1, 2009
Study CompletionOct 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 17.7 years ago